Cargando…

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients

INTRODUCTION: Previous studies have shown a reduction in the effectiveness of primary COVID-19 vaccination in patients with rheumatic diseases. However, limited data is available regarding the effectiveness of the COVID-19 vaccine booster dose, especially on cellular response. The study aimed to ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wroński, Jakub, Jaszczyk, Bożena, Roszkowski, Leszek, Felis-Giemza, Anna, Bonek, Krzysztof, Kornatka, Anna, Plebańczyk, Magdalena, Burakowski, Tomasz, Lisowska, Barbara, Kwiatkowska, Brygida, Maśliński, Włodzimierz, Wisłowska, Małgorzata, Massalska, Magdalena, Ciechomska, Marzena, Kuca-Warnawin, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659732/ https://www.ncbi.nlm.nih.gov/pubmed/36389719 http://dx.doi.org/10.3389/fimmu.2022.1033804

Ejemplares similares

The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
por: Wroński, Jakub, et al.
Publicado: (2023)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
por: Bonek, Krzysztof, et al.
Publicado: (2022)

Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
por: Bonek, Krzysztof, et al.
Publicado: (2021)

Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4(+)Foxp3(+) Treg Induction
por: Massalska, Magdalena, et al.
Publicado: (2022)

S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs
por: Roszkowski, Leszek, et al.
Publicado: (2022)

Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes
por: Ciechomska, Marzena, et al.
Publicado: (2023)

Potential Mechanism of Fatigue Induction and Its Management by JAK Inhibitors in Inflammatory Rheumatic Diseases
por: Felis-Giemza, Anna, et al.
Publicado: (2023)

Different Secretory Activity of Articular and Subcutaneous Adipose Tissues from Rheumatoid Arthritis and Osteoarthritis Patients
por: Plebańczyk, Magdalena, et al.
Publicado: (2018)

Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
por: Massalska, Magdalena, et al.
Publicado: (2020)

Rheumatoid arthritis bone marrow environment supports Th17 response
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2017)

Basic Properties of Adipose-Derived Mesenchymal Stem Cells of Rheumatoid Arthritis and Osteoarthritis Patients
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2023)

Impact of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Rheumatic Disease Patients on T Helper Cell Differentiation
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2022)

Associations of IL-18 with Altered Cardiovascular Risk Profile in Psoriatic Arthritis and Ankylosing Spondylitis
por: Bonek, Krzysztof, et al.
Publicado: (2022)

Inhibition of Allogeneic and Autologous T Cell Proliferation by Adipose-Derived Mesenchymal Stem Cells of Ankylosing Spondylitis Patients
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2021)

Direct anti-proliferative effect of adipose-derived mesenchymal stem cells of ankylosing spondylitis patients on allogenic CD4+ cells
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2021)

Different expression of chemokines in rheumatoid arthritis and osteoarthritis bone marrow
por: Kuca-Warnawin, Ewa H., et al.
Publicado: (2016)

CD4(+)FOXP3(+) T Cells in Rheumatoid Arthritis Bone Marrow Are Partially Impaired
por: Massalska, Magdalena, et al.
Publicado: (2020)

Monocyte-related biomarkers of rheumatoid arthritis development in undifferentiated arthritis patients – a pilot study
por: Kurowska, Weronika, et al.
Publicado: (2018)

DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis
por: Ciechomska, Marzena, et al.
Publicado: (2019)

The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis
por: Kurowska, Weronika, et al.
Publicado: (2017)

Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients
por: Ciechomska, Marzena, et al.
Publicado: (2018)

Bone marrow as a secondary lymphoid organ: mature T-cell subsets in bone marrow from rheumatoid arthritis and osteoarthritis patients
por: Warnawin, E, et al.
Publicado: (2005)

Distinct lymphocyte subpopulations in bone marrow from rheumatoid arthritis and osteoarthritis patients: a role for IL-15?
por: Maslinski, W, et al.
Publicado: (2004)

Interleukin 6 blockage-induced neutropenia in a patient with rheumatoid arthritis and resolved hepatitis B
por: Chmielińska, Magdalena, et al.
Publicado: (2016)

Cytokines and integrins related to inflammation of joint and gut in patients with spondyloarthritis and inflammatory bowel disease
por: Kontny, Ewa, et al.
Publicado: (2017)

Toll-like receptor 9 agonists and IL-15 promote activation, proliferation, secretion of proinflammatory cytokines and differentiation of B cells isolated from bone marrow of rheumatoid arthritis patients
por: Rudnicka, W, et al.
Publicado: (2007)

Enthesopathies and enthesitis. Part 1. Etiopathogenesis
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2015)

Interleukin-15 as a Biomarker Candidate of Rheumatoid Arthritis Development
por: Kurowska, Weronika, et al.
Publicado: (2020)

Modulation of T-Cell Activation Markers Expression by the Adipose Tissue–Derived Mesenchymal Stem Cells of Patients with Rheumatic Diseases
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2020)

Modulatory Impact of Adipose-Derived Mesenchymal Stem Cells of Ankylosing Spondylitis Patients on T Helper Cell Differentiation
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2021)

Tuning Monocytes and Macrophages for Personalized Therapy and Diagnostic Challenge in Rheumatoid Arthritis
por: Roszkowski, Leszek, et al.
Publicado: (2021)

Significance of bone marrow edema in pathogenesis of rheumatoid arthritis
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2013)

Enthesopathies and enthesitis. Part 2: Imaging studies
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2015)

The Phenotype and Secretory Activity of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Patients with Rheumatic Diseases
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2019)

Functional Toll-like receptor 9 modulates the activity of bone marrow B cells isolated from rheumatoid arthritis patients
por: Rudnicka, W, et al.
Publicado: (2005)

The pathogenesis of rheumatoid arthritis in radiological studies. Part I: Formation of inflammatory infiltrates within the synovial membrane
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2012)

Capillaroscopy – a role in modern rheumatology
por: Chojnowski, Marek M., et al.
Publicado: (2016)

Is intra-articular infliximab therapy a good alternative to radionuclide synovectomy for a patient with refractory pigmented villonodular synovitis?
por: Felis-Giemza, Anna, et al.
Publicado: (2021)

Antimalarials – are they effective and safe in rheumatic diseases?
por: Haładyj, Ewa, et al.
Publicado: (2018)

Combination Treatment of Locoregionally Aggressive Granulomatosis with Polyangiitis and Cranial Base Infiltration
por: Bonek, Krzysztof, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4nj4de6j35n3mph413eoj8rupc